NewsCoronavirus

Actions

Louisville COVID-19 patient to participate in clinical study

Default-Image_1280x720.png
Posted at 9:43 AM, Apr 21, 2020
and last updated 2020-04-21 09:43:22-04

LOUISVILLE, Ky. (LEX 18) — A Louisville coronavirus patient will be one of the first in the world to participate in a clinical study focusing on the effectiveness of a cancer drug on COVID-19.

According to Norton Healthcare, the drug is showing promise in blocking a cellular protein that researchers believe is linked to spreading COVID-19 to cells in the body.

The clinical trial is being conducted at 40 locations globally.

A hematologist and oncologist with Norton Cancer Institute is leading the local study.